Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 171 Lymphoma 93 Leukemia 63 Burkitt Lymphoma 57 Lymphoma, Non-Hodgkin 50 Lymphoma, Large B-Cell, Diffuse 44 Lymphoma, Mantle-Cell 38 Lymphoma, Follicular 30 Recurrence 29 Hodgkin Disease 29 Waldenstrom Macroglobulinemia 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 27 Leukemia, Lymphocytic, Chronic, B-Cell 26 Multiple Myeloma 21 Lymphoma, B-Cell, Marginal Zone 17 Lymphoma, Extranodal NK-T-Cell 16 Leukemia, Biphenotypic, Acute 16 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, B-Cell 13 Leukemia, Myeloid, Acute 13 Lymphoma, Large-Cell, Immunoblastic 11 Lymphoma, T-Cell, Peripheral 10 Neoplasms 9 Lymphoma, Large-Cell, Anaplastic 9 Lymphoma, T-Cell, Cutaneous 8 Lymphoma, T-Cell 7 Intraocular Lymphoma 6 Hematologic Neoplasms 6 Blast Crisis 6 Sezary Syndrome 5

Interventions

midostaurin 2 selinexor 1 pegfilgrastim 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Aggression × Dexamethasone × Lymphoid × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡